Trials / Completed
CompletedNCT01181908
Alcohol Interaction Study
A Study to Investigate the Psychomotor and Cognitive Effects of Alcohol When Co-administered With GSK1144814 or Matching Placebo in Healthy Subjects.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is understand the effects of GSK114814 and alcohol in healthy volunteers when taken together.
Detailed description
The primary objective of this study is to investigate the CNS effects of co-administration of GSK1144814 with alcohol. Healthy volunteers who meet the eligibility criteria will be randomized to receive GSK1144814 or placebo with alcohol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | single dose | Subjects will receive a single dose of GSK1144814 or placebo. |
Timeline
- Start date
- 2009-11-11
- Primary completion
- 2009-12-30
- Completion
- 2009-12-30
- First posted
- 2010-08-13
- Last updated
- 2017-06-27
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01181908. Inclusion in this directory is not an endorsement.